Comparative Effectiveness Analysis of Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease and Unprotected Left Main Coronary Artery Disease :Insights From a Large-Sized All-Comers Registry

EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Dae-Won KimDuk-Woo Park

Abstract

Outcomes according to the status of renal insufficiency were not fully evaluated in left main coronary artery disease (LMCAD). Among 4894 patients with LMCAD, renal insufficiency was graded according to the estimated glomerular filtration rate (eGFR). The primary outcome was major adverse cardiocerebrovascular event (MACCE), defined as death, myocardial infarction, stroke, or any revascularization. 3,824 (78%) had group 1 (eGFR ≥60 ml·min -1·1.73m2), 838 (17%) had group 2 (eGFR ≥ 30 and <60), and 232 (5%) had group 3 (eGFR <30). At 2 years, after adjustment, compared with group 1, the risk of MACCE was significantly higher in group 2 (hazard ratio [HR] 1.46, 95% confidence interval [CI] 1.18-1.79) and in group 3 (HR 3.39, 95% CI 2.61-4.40). Meanwhile, the P interaction for MACCE across groups was 0.20. The adjusted risk of MACCE was similar between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in group 1 or 2. However, PCI was associated with a significantly higher risk of MACCE compared to CABG (HR 1.88, 95% CI 1.08-3.25) in group 3. The degree of renal insufficiency was proportionately associated with unfavorable outcomes in patients with LMCAD. In group 3, PCI was associated with a...Continue Reading

References

Jul 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P S ParfreyP E Barre
Jul 8, 2000·Kidney International·A K CheungA S Levey
Mar 30, 2002·Journal of the American College of Cardiology·Patricia J M BestPeter B Berger
Mar 13, 2003·Kidney International·Kamyar Kalantar-ZadehJoel D Kopple
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Nov 3, 2004·Journal of the American College of Cardiology·Patricia J M BestUNKNOWN PRESTO Investigators
Dec 22, 2005·American Heart Journal·Daniel J BlackmanVladimir Dzavik
Jun 2, 2006·Journal of the American Society of Nephrology : JASN·Marcello TonelliAmit X Garg
Oct 24, 2006·The American Journal of Cardiology·George D GiannoglouGeorge E Louridas
Feb 21, 2009·The New England Journal of Medicine·Patrick W SerruysUNKNOWN SYNTAX Investigators
Feb 10, 2010·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Pascal VranckxPatrick W Serruys
Apr 6, 2011·The New England Journal of Medicine·Seung-Jung ParkKi Bae Seung
Aug 11, 2018·Journal of the American College of Cardiology·Gennaro GiustinoGregg W Stone

❮ Previous
Next ❯

Citations

May 23, 2020·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Gennaro Giustino, Gregg W Stone
Aug 3, 2020·Current Opinion in Cardiology·Malak ElbatarnyBobby Yanagawa
Nov 15, 2020·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Andreas SchaeferUNKNOWN TiCAB investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.